Published in Am J Addict on September 20, 2007
An evidence based review of acute and long-term effects of cannabis use on executive cognitive functions. J Addict Med (2011) 2.06
Dronabinol for the treatment of cannabis dependence: a randomized, double-blind, placebo-controlled trial. Drug Alcohol Depend (2011) 1.62
A preliminary trial: double-blind comparison of nefazodone, bupropion-SR, and placebo in the treatment of cannabis dependence. Am J Addict (2009) 1.35
Candidate genes for cannabis use disorders: findings, challenges and directions. Addiction (2009) 1.31
A proof-of-concept randomized controlled study of gabapentin: effects on cannabis use, withdrawal and executive function deficits in cannabis-dependent adults. Neuropsychopharmacology (2012) 1.29
Cannabinoids in health and disease. Dialogues Clin Neurosci (2007) 1.28
Treatment of substance abusing patients with comorbid psychiatric disorders. Addict Behav (2011) 1.22
Pharmacotherapy for cannabis dependence: how close are we? CNS Drugs (2009) 1.19
Identifying new cannabis use with urine creatinine-normalized THCCOOH concentrations and time intervals between specimen collections. J Anal Toxicol (2009) 1.16
The dose effects of short-term dronabinol (oral THC) maintenance in daily cannabis users. Drug Alcohol Depend (2012) 1.14
Double-blind fluoxetine trial in comorbid MDD-CUD youth and young adults. Drug Alcohol Depend (2010) 1.13
A placebo-controlled trial of buspirone for the treatment of marijuana dependence. Drug Alcohol Depend (2009) 1.10
Sleep disturbance and the effects of extended-release zolpidem during cannabis withdrawal. Drug Alcohol Depend (2011) 1.08
The endocannabinoid system as a target for the treatment of cannabis dependence. Neuropharmacology (2008) 1.07
Project reduce: reducing alcohol and marijuana misuse: effects of a brief intervention in the emergency department. Addict Behav (2012) 1.07
Pharmacological treatment of cannabis dependence. Curr Pharm Des (2011) 1.04
Pharmacotherapies for cannabis dependence. Cochrane Database Syst Rev (2014) 1.03
A randomized double-blind, placebo-controlled trial of venlafaxine-extended release for co-occurring cannabis dependence and depressive disorders. Addiction (2013) 1.01
Reward-related brain response and craving correlates of marijuana cue exposure: a preliminary study in treatment-seeking marijuana-dependent subjects. J Addict Med (2013) 0.93
Crude estimates of cannabis-attributable mortality and morbidity in Canada-implications for public health focused intervention priorities. J Public Health (Oxf) (2015) 0.91
Treatment of co-occurring alcohol and other drug use disorders. Alcohol Res Health (2008) 0.90
Cognitive function as an emerging treatment target for marijuana addiction. Exp Clin Psychopharmacol (2010) 0.90
Latest advances in novel cannabinoid CB(2) ligands for drug abuse and their therapeutic potential. Future Med Chem (2012) 0.90
Treatment of Co-occurring Depression and Substance Dependence: Using Meta-analysis to Guide Clinical Recommendations. Psychiatr Ann (2008) 0.89
Delta9-tetrahydrocannabivarin testing may not have the sensitivity to detect marijuana use among individuals ingesting dronabinol. Drug Alcohol Depend (2009) 0.89
[Pharmacological and psychosocial interventions for cannabis use disorders]. Rev Bras Psiquiatr (2010) 0.88
Buspirone treatment of cannabis dependence: A randomized, placebo-controlled trial. Drug Alcohol Depend (2015) 0.86
Substance use among victimized women on probation and parole. Subst Use Misuse (2013) 0.85
Behavioral therapies for treatment-seeking cannabis users: a meta-analysis of randomized controlled trials. Eval Health Prof (2014) 0.85
Novel medications to treat addictive disorders. Curr Psychiatry Rep (2008) 0.85
Psychosocial interventions for cannabis use disorder. Cochrane Database Syst Rev (2016) 0.81
The safety of modafinil in combination with oral ∆9-tetrahydrocannabinol in humans. Pharmacol Biochem Behav (2010) 0.78
No Smoke without Tobacco: A Global Overview of Cannabis and Tobacco Routes of Administration and Their Association with Intention to Quit. Front Psychiatry (2016) 0.77
Effects of fixed or self-titrated dosages of Sativex on cannabis withdrawal and cravings. Drug Alcohol Depend (2016) 0.76
Vilazodone for cannabis dependence: A randomized, controlled pilot trial. Am J Addict (2015) 0.76
TREATMENT TRIAL AND LONG-TERM FOLLOW-UP EVALUATION AMONG COMORBID YOUTH WITH MAJOR DEPRESSION AND A CANNABIS USE DISORDER. Int J Med Biol Front (2012) 0.75
Assessing TLI as a Predictor of Treatment Seeking for SUD among Youth Transitioning to Young Adulthood. Adv Psychol Res (2013) 0.75
Treatment of depression in patients with alcohol or other drug dependence: a meta-analysis. JAMA (2004) 4.12
Priority actions to improve the care of persons with co-occurring substance abuse and other mental disorders: a call to action. Biol Psychiatry (2004) 1.39
A preliminary trial: double-blind comparison of nefazodone, bupropion-SR, and placebo in the treatment of cannabis dependence. Am J Addict (2009) 1.35
A randomized placebo-controlled trial of gabapentin for cocaine dependence. Drug Alcohol Depend (2005) 1.31
Extended-release mixed amphetamine salts and topiramate for cocaine dependence: a randomized controlled trial. Biol Psychiatry (2012) 1.18
Treatment of depression in patients with opiate dependence. Biol Psychiatry (2004) 1.16
Quantification and comparison of marijuana smoking practices: blunts, joints, and pipes. Drug Alcohol Depend (2010) 1.15
Psychostimulant treatment of cocaine dependence. Psychiatr Clin North Am (2012) 1.12
A pilot double-blind treatment trial of memantine for alcohol dependence. Alcohol Clin Exp Res (2007) 1.11
Association between cannabis use, psychosis, and schizotypal personality disorder: findings from the National Epidemiologic Survey on Alcohol and Related Conditions. Schizophr Res (2013) 1.10
Mindfulness impairments in individuals seeking treatment for substance use disorders. Am J Drug Alcohol Abuse (2011) 1.10
Response to cocaine, alone and in combination with methylphenidate, in cocaine abusers with ADHD. Drug Alcohol Depend (2005) 1.08
Changes in mood, cognitive performance and appetite in the late luteal and follicular phases of the menstrual cycle in women with and without PMDD (premenstrual dysphoric disorder). Horm Behav (2008) 1.06
Utility of lead-in period in cocaine dependence pharmacotherapy trials. Drug Alcohol Depend (2005) 1.06
Training physicians to treat substance use disorders. Curr Psychiatry Rep (2008) 1.06
The emerging role of meditation in addressing psychiatric illness, with a focus on substance use disorders. Harv Rev Psychiatry (2009) 1.05
Evaluation of a combined online and in person training in the use of buprenorphine. Subst Abus (2006) 1.04
Adult ADHD and substance abuse: diagnostic and treatment issues. Subst Use Misuse (2005) 1.04
Uses of coercion in addiction treatment: clinical aspects. Am J Addict (2008) 1.04
Alcohol increases impulsivity and abuse liability in heavy drinking women. Exp Clin Psychopharmacol (2012) 1.02
A placebo-controlled trial of memantine for cocaine dependence with high-value voucher incentives during a pre-randomization lead-in period. Drug Alcohol Depend (2010) 1.01
Comparison of intranasal methamphetamine and d-amphetamine self-administration by humans. Addiction (2012) 1.00
Course of weight change during naltrexone versus methadone maintenance for opioid-dependent patients. J Opioid Manag (2011) 0.98
Attention-deficit/hyperactivity disorder and early-onset substance use disorders. J Child Adolesc Psychopharmacol (2005) 0.97
Assessment of riboflavin as a tracer substance: comparison of a qualitative to a quantitative method of riboflavin measurement. Drug Alcohol Depend (2012) 0.94
Response to alcohol in females with a paternal history of alcoholism. Psychopharmacology (Berl) (2003) 0.94
Psychiatric comorbidity in treatment-seeking substance use disorder patients with and without attention deficit hyperactivity disorder: results of the IASP study. Addiction (2013) 0.92
Acute and residual interactive effects of repeated administrations of oral methamphetamine and alcohol in humans. Psychopharmacology (Berl) (2011) 0.92
Naltrexone treatment for opioid dependence: does its effectiveness depend on testing the blockade? Drug Alcohol Depend (2013) 0.92
A placebo controlled trial of memantine as an adjunct to oral naltrexone for opioid dependence. Drug Alcohol Depend (2011) 0.92
Treatment of Co-occurring Depression and Substance Dependence: Using Meta-analysis to Guide Clinical Recommendations. Psychiatr Ann (2008) 0.89
Unobserved versus observed office buprenorphine/naloxone induction: a pilot randomized clinical trial. Addict Behav (2010) 0.89
The International ADHD in Substance Use Disorders Prevalence (IASP) study: background, methods and study population. Int J Methods Psychiatr Res (2013) 0.89
Treating nicotine dependence by targeting attention-deficit/ hyperactivity disorder (ADHD) with OROS methylphenidate: the role of baseline ADHD severity and treatment response. J Clin Psychiatry (2013) 0.88
Response to alcohol in women: role of the menstrual cycle and a family history of alcoholism. Drug Alcohol Depend (2011) 0.87
Treating depression in substance abusers. Curr Psychiatry Rep (2006) 0.87
Concurrent cannabis use during treatment for comorbid ADHD and cocaine dependence: effects on outcome. Am J Drug Alcohol Abuse (2006) 0.87
Treatment strategies for co-occurring ADHD and substance use disorders. Am J Addict (2007) 0.87
The effects of progesterone pretreatment on the response to oral d-amphetamine in Women. Horm Behav (2010) 0.86
Validity of the Adult ADHD Self-Report Scale (ASRS) as a screener for adult ADHD in treatment seeking substance use disorder patients. Drug Alcohol Depend (2013) 0.86
Comparison of olanzapine to risperidone in substance-abusing individuals with schizophrenia. Am J Addict (2007) 0.85
Pediatric obesity: parallels with addiction and treatment recommendations. Harv Rev Psychiatry (2008) 0.85
Predictors of treatment contact among individuals with cannabis dependence. Am J Drug Alcohol Abuse (2004) 0.85
Predictors of cannabis dependence recovery among epidemiological survey respondents in the United States. Am J Drug Alcohol Abuse (2007) 0.84
Antiretroviral medication: an emerging category of prescription drug misuse. Am J Addict (2013) 0.84
Does Attention Deficit Hyperactivity Disorder increase the risk of suicide attempts? J Affect Disord (2011) 0.83
A comparison of psychosocial and cognitive functioning between depressed and non-depressed patients with cannabis dependence. J Addict Dis (2010) 0.83
Screening and intervention for alcohol and illicit drug abuse:a survey of internal medicine housestaff. J Addict Dis (2005) 0.83
Early abstinence in cocaine dependence: influence of comorbid major depression. Am J Addict (2007) 0.83
A comparison of independent depression and substance-induced depression in cannabis-, cocaine-, and opioid-dependent treatment seekers. Am J Addict (2011) 0.82
Smoking and psychopathology increasingly associated in recent birth cohorts. Drug Alcohol Depend (2013) 0.82
The self-medication hypothesis and psychostimulant treatment of cocaine dependence: an update. Am J Addict (2013) 0.81
Assessment of cognitive functioning of methadone-maintenance patients: impact of adult ADHD and current cocaine dependence. J Addict Dis (2006) 0.81
Pharmacotherapy for alcohol-related disorders: what clinicians should know. Harv Rev Psychiatry (2005) 0.81
Socially sanctioned coercion mechanisms for addiction treatment. Am J Addict (2007) 0.81
Improving temporal efficiency of outpatient buprenorphine induction. Am J Addict (2011) 0.80
The interface between substance abuse and chronic pain management in primary care: a curriculum for medical residents. Subst Abus (2009) 0.80
Levetiracetam for the treatment of co-occurring alcohol dependence and anxiety: case series and review. Am J Drug Alcohol Abuse (2008) 0.80
Does remission from alcohol and drug use disorders increase the likelihood of smoking cessation among nicotine dependent young adults? Soc Psychiatry Psychiatr Epidemiol (2008) 0.80
The effects of alcohol and drug dependence on the course of depression. Am J Addict (2006) 0.79
Impact of a brief training on medical resident screening for alcohol misuse and illicit drug use. Am J Addict (2008) 0.79
Substance abuse among patients with schizophrenia. J Psychiatr Pract (2002) 0.78
The "younger-sibling-at-risk design": a pilot study of adolescents with ADHD and an older sibling with substance use disorder. Am J Drug Alcohol Abuse (2011) 0.78
Quetiapine treatment of zolpidem dependence. Am J Addict (2007) 0.78
Comparison of substance use milestones in cannabis- and cocaine-dependent patients. J Addict Dis (2012) 0.78
Comparison of clinical trial recruitment populations: treatment-seeking characteristics of opioid-, cocaine-, and cannabis-using participants. J Subst Abuse Treat (2011) 0.78
Specificity of verbal learning impairment and recovery in a marijuana-dependent male: the effects of sustained marijuana abstinence. Cogn Neuropsychiatry (2011) 0.77
Open-label pilot study of quetiapine treatment for cannabis dependence. Am J Drug Alcohol Abuse (2014) 0.77
Verbal learning in marijuana users seeking treatment: a comparison between depressed and non-depressed samples. Am J Drug Alcohol Abuse (2014) 0.77
Risk Factors for Borderline Personality Disorder in Treatment Seeking Patients with a Substance Use Disorder: An International Multicenter Study. Eur Addict Res (2015) 0.77
Demographic and clinical characteristics of middle-aged versus younger adults enrolled in a clinical trial of a web-delivered psychosocial treatment for substance use disorders. J Addict Med (2013) 0.76
Antisocial behavioral syndromes in cocaine and cannabis dependence. Am J Drug Alcohol Abuse (2008) 0.76
One-year follow-up study of suicide attempters treated for drug dependence. Am J Addict (2006) 0.76
First treatment contact for ADHD: predictors of and gender differences in treatment seeking. Psychiatr Serv (2014) 0.76
Effects of research setting on observed depressive symptoms in marijuana users. J Subst Abuse Treat (2009) 0.75
Individual mindfulness-based psychotherapy for cannabis or cocaine dependence: a pilot feasibility trial. Am J Addict (2013) 0.75
Toward personalized smoking-cessation treatment: Using a predictive modeling approach to guide decisions regarding stimulant medication treatment of attention-deficit/hyperactivity disorder (ADHD) in smokers. Am J Addict (2015) 0.75
Pharmacological Treatment of ADHD in Addicted Patients: What Does the Literature Tell Us? Harv Rev Psychiatry (2017) 0.75
Verbal abilities as predictors of retention among adolescents in a therapeutic community. Child Psychiatry Hum Dev (2006) 0.75